Navigation Links
HRID Announces Growth and Expansion
Date:3/1/2012

FORT LAUDERDALE, Fla., March 1, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, soon to be changed from Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today that it is hiring a team of consumer marketing experts to position the Company as well as its current and pending portfolio of products to the market place.

The marketing team will focus initially on further developing the brand and consumer education strategy for the Azul Instant™ product.  Consumer response rates to the all-natural product offering have exceeded the Company's expectations to date and with the right marketing approach, the Company believes the product will quickly surpass competitive products globally. 

Nouveau Life's mission is to be the leading provider of safe and healthy remedies for those suffering with common medical conditions.  The Company's initial products have been developed to provide the millions of people suffering with sexual dysfunction with a solution comprised of all-natural ingredients.  Plans are now underway to expand the portfolio to launch all-natural supplements for weight loss, acne and high cholesterol.  The team of consumer marketing experts will be charged with building global brand strategies and consumer awareness campaigns across the Company's entire portfolio of product offerings.       

"Those of us that have been in the business for a long time can attest to the fact that marketing rules have changed.  Marketing strategies that worked just a few years ago are no longer producing the same results.  Consumers have more options today than any point in history.  We believe the key to our success is employing innovative marketing techniques to educate the consumer on our brands, reduce consumer risk, and utilize feedback to drive loyalty and satisfaction.  The selection
'/>"/>

SOURCE Nouveau Life Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - ... GBI Research, a leading business intelligence provider, has released ... to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New ... 2013, along with forecasts until 2020 for the ... China , Australia ...
(Date:6/3/2015)... Fla. , June 3, 2015   ... adolescents and teens nationwide has prompted The Addiction ... detects drug usage in just 5 minutes. The ... with the tools to drug test for thirteen ... teens. Delivered in confidential packaging with instructions and ...
(Date:6/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/t3kkhg/the_future_of ) ... Future of Pharmaceutical Outsourcing" report to their ... desperate need to develop better drugs with high ... been increasingly utilizing external resources to increase their ... their internal operation. Their outsourcing demands and proportions ...
Breaking Medicine Technology:Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches 2Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches 3Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches 4The Drug Detective Is A Simple Test That Could Save Your Child's Life 2The Future of Pharmaceutical Outsourcing: 2015 Report 2
(Date:6/3/2015)... On June 22, 2015, Medicare will ... sensitivity (pharmacogenetic) testing that it has reimbursed since 2009. ... 19 million of the 49 million Medicare beneficiaries in the ... adverse drug events.(1) Sadly, if it became a standard of ... the use of an individual’s genetic information to tailor treatment, ...
(Date:6/3/2015)... 2015 Horizon Blue Cross Blue Shield of ... one of the nation’s top employers for diverse managers and ... its national list of Best Places for Diverse Managers and ... 1 Regional Company. This is the sixth consecutive year ... for its diverse workplace policies and programs. , Companies are ...
(Date:6/3/2015)... A group of nine authors involved with TransCelerate ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Author(s) of the Year Award, which acknowledges an ... a significant impact in advancing medical product development, published ...
(Date:6/3/2015)... Visual BI Solutions, a leader in ... launch of the second release of its successful ... Studio. The Design Studio EXtension suite allows customers ... into their dashboarding projects. , With the second ... adding key components for customers that are looking ...
(Date:6/3/2015)... 2015 Sitting at a computer for ... the back, neck, shoulders and/or wrists. This can lead ... addition, recent research links sitting for long periods as ... Fortunately, three inventors from Oakville, Ontario, are offering an ... , They have developed a prototype for a patent-pending ...
Breaking Medicine News(10 mins):Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2
... CHICAGO --- When people finish treatment for cancer, they want ... as possible. But a new Northwestern Medicine study -- one ... survivors still suffer moderate to severe problems with pain, fatigue, ... has ended. "We were surprised to see how prevalent ...
... which is the most lethal type of skin cancer, the results ... the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival. ... the June 2 issue of New England Journal of Medicine ... and one of the first in all cancers to show clinical ...
... and Infectious Diseases (NIAID), part of the National Institutes of ... HIV shut down, and how they can be reactivated. ... proteins that the immune system can use, like the gas ... cell or to damp down its activity. However, in people ...
... , FRIDAY, June 3 (HealthDay News) -- A new ... (MRSA) has been detected in cows, milk in ... Holmes, of the department of veterinary medicine at the ... that this new variant, which is genetically different than ...
... in San Diego from 12-16 June for an annual ... arts--including, this year, a focus on mummies. The ... tsunamis and storm surges; the changing dynamics of Antarctic ... and the intersection of science with music, literature, and ...
... the AIDS epidemic, a once-rare form of cancer known as ... Its stigma was best illustrated by Tom Hanks, who portrayed ... from his co-workers in the 1993 movie "Philadelphia." A ... young virologist searching for a postdoctoral position. He found one, ...
Cached Medicine News:Health News:Cancer survivors can't shake pain, fatigue, insomnia, foggy brain 2Health News:Cancer survivors can't shake pain, fatigue, insomnia, foggy brain 3Health News:Vaccine first to show improved survival rates for metastatic melanoma 2Health News:Vaccine first to show improved survival rates for metastatic melanoma 3Health News:AAAS Pacific Division to convene joint session with world mummy scholars in San Diego 2Health News:AAAS Pacific Division to convene joint session with world mummy scholars in San Diego 3Health News:FSU scientist leads research on AIDS-related cancer 2Health News:FSU scientist leads research on AIDS-related cancer 3
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
... Accelerated Bacterial Enumeration System. Bacterial concentration is ... found by the volume dispensed in the ... decreasing volume of sample is dispensed on ... in an Archimedes spiral. The volume is ...
... analyses the Petri dishes and counts the ... reproducible results. A CCD camera positioned above ... a dedicated computer. The counting alogrithms enable ... compensate for spreading and confluent colonies. The ...
... Gas Monitoring System provides a ... measurements of pH, pCO2, pO2 ... artery (e.g. radial, femoral or ... of O2 saturation; base-excess and ...
Medicine Products: